title: Oncology and haematology in 2013. Some advances, but too many new treatments with an inadequately assessed harm-benefit balance.
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006401:Hematologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006405:Hematology / Q000379:methods*; D006801:Humans; D008495:Medical Oncology / Q000379:methods*; D018579:Patient Selection; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D006401:Hematologic Agents